Amedeo's Top 20

Amedeo Smart

Independent Medical Education

30 November 2015

Multidisciplinary Journal Club

  1. Gerasimidis K, Bertz M, Hanske L, Junick J, et al.
    Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition.
    Inflamm Bowel Dis 2014;20:861-71.

  1. Curry MP, O'Leary JG, Bzowej N, Muir AJ, et al.
    Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
    N Engl J Med 2015.

  2. Bernal W, Jalan R, Quaglia A, Simpson K, et al.
    Acute-on-chronic liver failure.
    Lancet 2015;386:1576-87.

  3. Avezum A, Lopes RD, Schulte PJ, Lanas F, et al.
    Apixaban Compared with Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the ARISTOTLE Trial.
    Circulation 2015.

  4. Ward JW, Mermin JH.
    Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs.
    N Engl J Med 2015.

  1. Wang J , Wu Y, Ma C, Fiorin G, et al.
    Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Proc Natl Acad Sci U S A 2013.

  2. Saliba F, Pascher A, Cointault O, Laterre PF, et al.
    Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.
    Clin Infect Dis 2014.

  3. Ellebedy AH , Lupfer C, Ghoneim HE, DeBeauchamp J, et al.
    Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.
    Proc Natl Acad Sci U S A 2011;108:2927-32.

  4. Carey EJ, Ali AH, Lindor KD.
    Primary biliary cirrhosis.
    Lancet 2015.

  5. Lok AS, McMahon BJ, Brown RS Jr, Wong JB, et al.
    Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.
    Hepatology 2015.

  1. Xie T , Liang J, Liu N, Wang Q, et al.
    MicroRNA-127 inhibits lung inflammation by targeting IgG Fcgamma receptor I.
    J Immunol 2012;188:2437-44.

  2. Sulli C , Banik SS, Schilling J, Moser A, et al.
    Detection of proton movement directly across viral membranes to identify novel influenza M2 inhibitors.
    J Virol 2013.

  3. Choo JA, Liu J, Toh X, Grotenbreg GM, et al.
    The immunodominant Influenza A virus M158-66 CTL epitope exhibits degenerate class I MHC restriction in humans.
    J Virol 2014.

  4. Zhao D, Fukuyama S, Yamada S, Lopes TJ, et al.
    Molecular determinants of virulence and stability of a reporter-expressing H5N1 influenza A virus.
    J Virol 2015.

  5. Liu J , Chen P, Jiang Y, Wu L, et al.
    A Duck Enteritis Virus-vectored Bivalent Live Vaccine Provides Fast and Complete Protection against H5N1 Avian Influenza Virus in Ducks.
    J Virol 2011.

  1. Schwarz TF , Flamaing J, Rumke HC, Penzes J, et al.
    A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged >/=65 years.
    Vaccine 2011.

  2. Gany F, Rau-Murthy R, Mujawar I.
    Increasing influenza vaccination in New York City taxi drivers: A community driven approach.
    Vaccine 2015.

  3. Morris JM, Roberts CL, Bowen JR, Patterson JA, et al.
    Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial.
    Lancet 2015.

  4. Mocellin S, Pilati P, Briarava M, Nitti D, et al.
    Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials.
    J Natl Cancer Inst 2016;108.

  5. Chit A, Roiz J, Briquet B, Greenberg DP, et al.
    Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.
    Vaccine 2014.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016